Schedule 13G ownership disclosure

CONATUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 20600T108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137774-15-000038
Form type
SC 13G/A
Filer
Histogen Inc.
CIK
CIK 1383701
Filed
Feb 02, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub